1. Home
  2. TEO vs PFE Comparison

TEO vs PFE Comparison

Compare TEO & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEO
    SELLHOLDBUYas of 6 hours ago
  • PFE
    SELLHOLDBUYas of 6 hours ago
  • Stock Information
  • Founded
  • TEO 1979
  • PFE 1849
  • Country
  • TEO Argentina
  • PFE United States
  • Employees
  • TEO N/A
  • PFE N/A
  • Industry
  • TEO Telecommunications Equipment
  • PFE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TEO Telecommunications
  • PFE Health Care
  • Exchange
  • TEO Nasdaq
  • PFE Nasdaq
  • Market Cap
  • TEO N/A
  • PFE 139.3B
  • IPO Year
  • TEO N/A
  • PFE N/A
  • Fundamental
  • Price
  • TEO $10.59
  • PFE $24.70
  • Analyst Decision
  • TEO Sell
  • PFE Buy
  • Analyst Count
  • TEO 2
  • PFE 13
  • Target Price
  • TEO $9.60
  • PFE $31.92
  • AVG Volume (30 Days)
  • TEO 130.8K
  • PFE 57.7M
  • Earning Date
  • TEO 05-07-2025
  • PFE 04-29-2025
  • Dividend Yield
  • TEO 2.75%
  • PFE 6.96%
  • EPS Growth
  • TEO N/A
  • PFE 284.33
  • EPS
  • TEO 0.46
  • PFE 1.41
  • Revenue
  • TEO $4,013,186,763.00
  • PFE $63,627,000,000.00
  • Revenue This Year
  • TEO $9.57
  • PFE $0.10
  • Revenue Next Year
  • TEO $14.91
  • PFE N/A
  • P/E Ratio
  • TEO $5.59
  • PFE $17.49
  • Revenue Growth
  • TEO N/A
  • PFE 6.84
  • 52 Week Low
  • TEO $5.52
  • PFE $24.31
  • 52 Week High
  • TEO $15.54
  • PFE $31.54
  • Technical
  • Relative Strength Index (RSI)
  • TEO 45.51
  • PFE 36.08
  • Support Level
  • TEO $9.88
  • PFE $25.50
  • Resistance Level
  • TEO $11.17
  • PFE $25.43
  • Average True Range (ATR)
  • TEO 0.59
  • PFE 0.48
  • MACD
  • TEO 0.00
  • PFE -0.14
  • Stochastic Oscillator
  • TEO 47.02
  • PFE 17.46

Stock Price Comparison Chart: TEO vs PFE

TEO
PFE
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April05101520253035404550556065TEO VS PFE

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use